Stiff-man syndrome: an overview
- PMID: 9578675
Stiff-man syndrome: an overview
Abstract
Fluctuating stiffness and paroxysmal spasms of the trunk and legs are the primary features of stiff-man syndrome and it's variants, progressive encephalomyelopathy with rigidity and myoclonus (PERM) and stiff-leg syndrome. The spasms characterized by hyperextension of the back and legs are both spontaneous as well as stimulus-sensitive. They can be excruciatingly painful and are frequently accompanied by symptoms of autonomic dysregulation. Hyperreflexia may be the only pathological finding on the neurological examination. Most patients show psychiatric disturbances suggestive of psychogenic movement disorder and this may cause delays in adequate pharmacotherapy. The disease progresses over the span of months to years rendering many patients wheelchair-bound or bedridden. GABA-mimetics are most effective in treating symptoms, but tolerance and life-threatening withdrawal symptoms are common drawbacks. For therapy-refractory patients, intrathecal baclofen represents a good alternative. The diagnosis is based on clinical, biochemical and electrophysiological findings. Spasmodic reflex myoclonus is observed in nearly all SMS patients. It consists of well-reproduced reflex EMG-activity commencing 50-80 ms after medial or tibial nerve stimulation and lasting several seconds thereafter. The activity is first myoclonic then spasmodic in nature, and commonly begins in the muscles most severely affected before spreading bidirectionally along the neuraxis. Spasmodic reflex myoclonus and the high incidence of antibodies against GAD are suggestive of an autoimmune disorder affecting GABAergic neurons in the spinal cord, but the precise locus of dysfunction remains to be elucidated.
Similar articles
-
Focal stiff-person syndrome.Neurologia. 2001 Feb;16(2):89-91. Neurologia. 2001. PMID: 11257937
-
Stiff man syndrome and related conditions.Mov Disord. 2002 Sep;17(5):853-66. doi: 10.1002/mds.10279. Mov Disord. 2002. PMID: 12360534 Review.
-
[Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].Med Clin (Barc). 1998 Mar 21;110(10):378-81. Med Clin (Barc). 1998. PMID: 9567281 Spanish.
-
[Stiff-person syndrome: a case report].Rev Neurol. 2008 Sep 1-15;47(5):249-52. Rev Neurol. 2008. PMID: 18780271 Spanish.
-
Stiff Person syndrome and other anti-GAD-associated neurologic disorders.Semin Neurol. 2012 Nov;32(5):544-9. doi: 10.1055/s-0033-1334477. Epub 2013 May 15. Semin Neurol. 2012. PMID: 23677666 Review.
Cited by
-
Anti-glutamic acid decarboxylase antibody positive neurological syndromes.Neurosciences (Riyadh). 2016 Jul;21(3):215-22. doi: 10.17712/nsj.2016.3.20150596. Neurosciences (Riyadh). 2016. PMID: 27356651 Free PMC article. Review.
-
Propofol restores the function of "hyperekplexic" mutant glycine receptors in Xenopus oocytes and mice.J Neurosci. 2004 Mar 3;24(9):2322-7. doi: 10.1523/JNEUROSCI.4675-03.2004. J Neurosci. 2004. PMID: 14999083 Free PMC article.
-
Disease-specific human glycine receptor alpha1 subunit causes hyperekplexia phenotype and impaired glycine- and GABA(A)-receptor transmission in transgenic mice.J Neurosci. 2002 Apr 1;22(7):2505-12. doi: 10.1523/JNEUROSCI.22-07-02505.2002. J Neurosci. 2002. PMID: 11923415 Free PMC article.
-
Stiff man syndrome.CNS Drugs. 2001;15(7):515-26. doi: 10.2165/00023210-200115070-00002. CNS Drugs. 2001. PMID: 11510622 Review.